This effect translates to a low risk of hypoglycemia in patients with type 2 diabetes treated with GLP-1RAs [42]
AI-enabled in silico approaches, in tandem with high-throughput target binding assays (e.g., small-molecule microarrays) and phenotypic screens (perhaps using cAMP+ as a readout), may further uncover some of these incredibly useful molecules
The stimulatory effects of GLP-1 on the HPA axis were not limited to rodents
They get frustrated because it takes several months to escalate the dose to the highest level and see the benefits. Theres no set timeline for when youll start seeing results
Aim for a consistent intake throughout the day
Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L